Your rheumatology team can help integrate all aspects of your care while prioritizing evidence-based approaches to managing rheumatoid arthritis
In close collaboration with Jens Juul Holst, we conducted a series of infusion studies on the satiety effects of other gut hormones including GLP-2 and PYY
Compound Receptors Peak trial weight loss Lean mass as share of loss Semaglutide (Ozempic/Wegovy) GLP-1 ~14.9% (STEP-1, 68 wk) ~39% Tirzepatide (Mounjaro/Zepbound) GLP-1 + GIP ~20.9% (SURMOUNT-1, 72 wk) ~25-40% Retatrutide GLP-1 + GIP + GCGR ~24.2% (Phase 2, 48 wk) Comparable class range Best for understanding the takeaway: the percentage of loss that is lean mass is roughly constant across the class
Among them are Henrys available medications, which put the company in a specific place compared to direct competitors
The hallmark symptoms of RLS include: Uncomfortable leg sensations described as crawling, creeping, pulling, throbbing, aching, or electric-like feelings deep within the legs Irresistible urge to move the legs to relieve the uncomfortable sensations Symptom onset or worsening during rest or inactivity , particularly in the evening or at night Temporary relief with movement such as walking, stretching, or rubbing the legs Circadian pattern with symptoms typically worsening in the evening and night hours RLS can be classified as primary (idiopathic) or secondary to underlying conditions
No claims are made or implied regarding weight loss, metabolic benefits, therapeutic results, or human use